Clinical Trial Update: Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing carboplatin plus paclitaxel versus carboplatin plus docetaxel in ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Glasgow | Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 3 | Status: COMPLETED